lifestyle.projectdiaspora.org

Author: Inovio Pharmaceuticals, Inc.

FDA Accepts for Review INOVIO’s BLA for INO-3107 for the Treatment of Adults with Recurrent Respiratory Papillomatosis (RRP)

December 29, 2025
INOVIO Reports Inducement Grant Under Inducement Plan

December 21, 2025
INOVIO Completes Rolling BLA Submission Seeking Accelerated Approval for INO-3107 as a Treatment for RRP in Adults

November 5, 2025